Indivior PLC (LON:INDV – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 1,238 and traded as low as GBX 1,230. Indivior shares last traded at GBX 1,238, with a volume of 8,457,898 shares changing hands.
Indivior Price Performance
The company has a quick ratio of 1.52, a current ratio of 0.83 and a debt-to-equity ratio of -170.06. The stock has a market cap of £1.93 billion, a P/E ratio of -1,026.48, a P/E/G ratio of -5.57 and a beta of 0.19. The firm has a 50 day moving average price of GBX 1,238 and a 200 day moving average price of GBX 1,209.37.
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder.
Read More
- Five stocks we like better than Indivior
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Your “birthright claim” just got activated
- Wall Street Stockpicker Names #1 Stock of 2026
- Turn your “dead money” into $306+ monthly (starting this month)
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
